Abstract:Pulmonary arterial hypertension (PAH) is a progressive fatal disease with a complex pathogenic mechanism. Recent studies report that nearly 60% of patients with PAH have metabolic syndrome (MS). Unrecognized glucose intolerance and insulin resistance were also shown to be common in PAH, raising the possibility that metabolic disease predisposes to PAH. Nevertheless, the mechanistic link between the PAH and metabolic disorders remains unexplored. Mitochondrial dysfunction (MD) is one of the primary pathogenic events tightly associated with PAH and MS/ type 2 diabetes pathobiology and could play a causative role in severe metabolic perturbations. We hypothesized that dysfunctional mitochondria are sufficient to initiate metabolic rearrangements associated with PAH and classical metabolic disorders. In this study, we used the recently established rat model reproducing a human mutation in the NFU1 protein, which is responsible for mitochondrial homeostasis. NFU1G206Crats develop a severe MD and spontaneously develop PAH characterized by increased right ventricle (RV) systolic pressure, RV hypertrophy, and obliterative disease of the small pulmonary arteries. An intraperitoneal glucose tolerance test (IPGTT) was used to assess the ability of NFU1G206Crats to metabolize glucose. Plasma insulin levels were measured to control insulin sensitivity. Pulmonary arterial smooth muscle cells (PASMCs) isolated from WT and NFU1G206C rats were used for measuring fatty acid oxidation (FAO) by Seahorse palmitate‐BSA oxidation assay, mitochondria isolations, and western blot analysis. After 5 hours of fasting, WT and NFU1G206C rats had the same baseline glucose levels (glucose (mg/dL) is 89.5±2.0 vs. 92.0±6.2; p=0.47 in WT (N=5) vs. NFU1G206C(N=6)). However, 15 min after glucose administration (2 g/kg), NFU1G206Cshowed significantly higher levels of blood glucose, which reached the peak by 30 min (193.4±32.3 vs. 340.8±50.1; p<0.05 in WT vs. NFU1G206C) and remained high even after 120 min, when the glucose level of WT rats reached the baseline (96.1±11.1 vs. 155.9±15.9; p<0.02 in WT vs. NFU1G206C). MD was also sufficient to induce a significantly delayed insulin response in NFU1G206Ccompared to WT, suggesting the reduced insulin sensitivity in rats with MD. We also discovered an upregulated expression of free fatty acid (FFA) transporters, CD36 and CPT1, in NFU1G206C PASMC, which corresponded to the increased levels of basal FAO in the mutant cells. This discovery was confirmed by mitochondrial proteome analysis, revealing a significantly upregulated FA metabolism and dysregulated FA synthesis in NFU1G206C PASMC. NFU1G206C PASMC also had an increased membrane translocation of PKCα, one of the diacylglycerol‐dependent PKCs activated by FFAs and involved in reduced insulin sensitivity. We conclude that the MD secondary to the NFU1 insufficiency induces significant metabolic derangements, such as increased flux of fatty acids, glucose intolerance, and insulin insensitivity associated with classic metabolic disorders and recently implemented in the pathogenesis of PAH. The severe metabolic reprogramming revealed in PASMC correlates with progressive pulmonary vascular disease in NFU1G206Crats.

Abstract 15168: The Role of Mitochondrial Fission Factor (MFF) and Increased Midzone Mitochondrial Fission in Pulmonary Arterial Hypertension: Implications for Proliferation, Mitophagy, and Apoptosis

Abstract 15702: Role of the Drp-1 Receptors Mid49 and Mid51 in Regulating Fission and Cell Proliferation in Pulmonary Arterial Hypertension

Abstract 12004: Mitochondrial Fission Mediator MiD49 Regulates Proliferation via MYO1C in Pulmonary Arterial Hypertension

PGC1α-mediated Mitofusin-2 Deficiency in Female Rats and Humans with Pulmonary Arterial Hypertension

ERK/Drp1‐dependent mitochondrial fission contributes to HMGB1‐induced autophagy in pulmonary arterial hypertension

Internet Technology: Resources for Perinatal Nurses

Role of Dynamin 2 in mitochondrial fission and cell cycle regulation: Dysregulation of a miR-124-3p-STAT3-DNM2-Drp1-RGCC pathway connects fission and cell proliferation in pulmonary arterial hypertension

The Role of Mitochondrial Dynamics and Mitotic Fission in Regulating the Cell Cycle in Cancer and Pulmonary Arterial Hypertension: Implications for Dynamin-Related Protein 1 and Mitofusin2 in Hyperproliferative Diseases

Mitofusin 2 Downregulation Triggers Pulmonary Artery Smooth Muscle Cell Proliferation and Apoptosis Imbalance in Rats With Hypoxic Pulmonary Hypertension Via the PI3K/Akt and Mitochondrial Apoptosis Pathways.

Hypoxia Promotes Pulmonary Vascular Remodeling Via HIF-1α to Regulate Mitochondrial Dynamics

FUNDC1-mediated mitophagy and HIF1α activation drives pulmonary hypertension during hypoxia

Role of mitochondrial PKD on right ventricular fibrosis under pulmonary hypertension

Mitochondrial Dysfunction Dictates Energy Metabolism Reprogramming in Pulmonary Arterial Hypertension

Inhibitors of Mitochondrial Dynamics Mediated by Dynamin-Related Protein 1 in Pulmonary Arterial Hypertension

Abstract 12591: Mitochondrial Dysfunction and Reticulocytes Maturation: Contribution to the Pathogenesis of Pulmonary Hypertension

Hypoxia Induces Pulmonary Artery Smooth Muscle Dysfunction Through Mitochondrial Fragmentation-Mediated Endoplasmic Reticulum Stress.

Acquired disorders of mitochondrial metabolism and dynamics in pulmonary arterial hypertension

STAT3 phosphorylation at Tyr705 affects DRP1 (dynamin-related protein 1) controlled-mitochondrial fission during the development of apoptotic-resistance in pulmonary arterial endothelial cells

Mitochondrial hyperfusion induces metabolic remodeling in lung endothelial cells by modifying the activities of electron transport chain complexes I and III

Reactive Oxygen Species Effect PASMCs Apoptosis Via Regulation of Dynamin-Related Protein 1 in Hypoxic Pulmonary Hypertension

Ubiquitinated AIF is a major mediator of hypoxia-induced mitochondrial dysfunction and pulmonary artery smooth muscle cell proliferation